Invention Grant
- Patent Title: Fibronectin type III domain proteins with enhanced solubility
-
Application No.: US16999291Application Date: 2020-08-21
-
Publication No.: US11512124B2Publication Date: 2022-11-29
- Inventor: Aaron P. Yamniuk , Stanley R. Krystek
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Main IPC: C12N15/00
- IPC: C12N15/00 ; C07K14/78
Abstract:
Provided herein are polypeptides comprising a modified fibronectin type III (Fn3) domain, wherein the amino acid corresponding to residue 58 of SEQ ID NO: 1 is mutated, and wherein the solubility is enhanced relative to the solubility of a Fn3 domain in which the amino acid corresponding to residue 58 of SEQ ID NO: 1 is not mutated. Also provided are libraries comprising a plurality of the polypeptides and a method for identifying a polypeptide that binds to a target.
Public/Granted literature
- US20210070840A1 FIBRONECTIN TYPE III DOMAIN PROTEINS WITH ENHANCED SOLUBILITY Public/Granted day:2021-03-11
Information query
IPC分类:
